Login to Your Account



Pharma: Other News To Note


Tuesday, March 26, 2013
Actavis Inc., of Parsippany, N.J., reached a settlement agreement with AstraZeneca plc, of London, resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5-, 10-, 20- and 40-mg tablets, the generic version of Crestor tablets, as well as Actavis' rosuvastatin zinc alternate salt product.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription